Our healthcare system is unfortunately marked by skyrocketing costs, especially when it comes to prescription drugs. For far too long, unnecessary barriers and outdated FDA requirements have prevented Americans from accessing a less expensive, generic version of their medication. That's why I introduced the bipartisan Biosimilar Red Tape Elimination Act alongside Congressman Greg Landsman (OH-01) to improve patient access to prescription medications and increase competition in the biological drug market by automatically deeming "biosimilar" drugs as interchangeable with their name-brand counterparts upon FDA approval. Read more about the legislation here.